EGFR and non-small cell lung carcinoma: For instance, in 2021, Chen et al. 47 discovered that EGFR could trigger T-cell immune dysfunction by activating immunoglobulin-like transcript 4 (ILT4), thereby mediating the immune escape of NSCLC cells.